Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chloe J Peach

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cell Chemical Biology|April 9, 2019
Complex Formation between VEGFR2 and the β<sub>2</sub>-AdrenoceptorLaura E Kilpatrick, Diana C Alcobia, Carl W White, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Neuropilin-1 is a co-receptor for Nerve Growth Factor-evoked painChloe J Peach, Raquel Tonello, Elisa Damo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2023
Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain reliefAlan Hegron, Chloe J Peach, Raquel Tonello, et al.
Biomaterials|October 15, 2025
Nanoparticle-mediated antagonism of sustained endosomal signaling of the calcitonin receptor-like receptor provides enhanced and persistent relief of oral cancer painChloe J Peach, Nguyen Huu Tu, Parker K Lewis, et al.
Biomaterials|October 17, 2024
PAR<sub>2</sub> on oral cancer cells and nociceptors contributes to oral cancer pain that can be relieved by nanoparticle-encapsulated AZ3451Divya Bhansali, Nguyen H Tu, Kenji Inoue, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2022
Mice expressing fluorescent PAR<sub>2</sub> reveal that endocytosis mediates colonic inflammation and painRocco Latorre, Alan Hegron, Chloe J Peach, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2025
Nanomedicines targeting protease-activated receptor 2 in endosomes provide sustained analgesiaShavonne L Teng, Rocco Latorre, Divya Bhansali, et al.
Nature Communications|September 25, 2025
Targeting prostaglandin E<sub>2</sub> receptor 2 in Schwann cells inhibits inflammatory pain but not inflammationRomina Nassini, Lorenzo Landini, Matilde Marini, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: Nuclear hormone receptorsStephen P H Alexander, John A Cidlowski, Alasdair J Gibb, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: TransportersStephen P H Alexander, Alasdair J Gibb, Eamonn Kelly, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cell Chemical Biology|April 9, 2019
Complex Formation between VEGFR2 and the β<sub>2</sub>-AdrenoceptorLaura E Kilpatrick, Diana C Alcobia, Carl W White, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Neuropilin-1 is a co-receptor for Nerve Growth Factor-evoked painChloe J Peach, Raquel Tonello, Elisa Damo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2023
Therapeutic antagonism of the neurokinin 1 receptor in endosomes provides sustained pain reliefAlan Hegron, Chloe J Peach, Raquel Tonello, et al.
Biomaterials|October 15, 2025
Nanoparticle-mediated antagonism of sustained endosomal signaling of the calcitonin receptor-like receptor provides enhanced and persistent relief of oral cancer painChloe J Peach, Nguyen Huu Tu, Parker K Lewis, et al.
Biomaterials|October 17, 2024
PAR<sub>2</sub> on oral cancer cells and nociceptors contributes to oral cancer pain that can be relieved by nanoparticle-encapsulated AZ3451Divya Bhansali, Nguyen H Tu, Kenji Inoue, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 3, 2022
Mice expressing fluorescent PAR<sub>2</sub> reveal that endocytosis mediates colonic inflammation and painRocco Latorre, Alan Hegron, Chloe J Peach, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2025
Nanomedicines targeting protease-activated receptor 2 in endosomes provide sustained analgesiaShavonne L Teng, Rocco Latorre, Divya Bhansali, et al.
Nature Communications|September 25, 2025
Targeting prostaglandin E<sub>2</sub> receptor 2 in Schwann cells inhibits inflammatory pain but not inflammationRomina Nassini, Lorenzo Landini, Matilde Marini, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: Nuclear hormone receptorsStephen P H Alexander, John A Cidlowski, Alasdair J Gibb, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: TransportersStephen P H Alexander, Alasdair J Gibb, Eamonn Kelly, et al.
Pageof 3